- Aktuelle Seite:
-
Home
-
Substanzen
-
Opioide
- Fentanyl
Fentanyl-Associated Overdose Deaths Outside the Hospital.
Jeffery MM, Stevens M, D'Onofrio G, Melnick ER.
N Engl J Med. 2023 Jul 6;389(1):87-88. doi: 10.1056/NEJMc2304991. Epub 2023 Jun 21. PMID: 37342960; PMCID: PMC10388669.
https://www.nejm.org/doi/10.1056/NEJMc2304991
Illicitly Manufactured Fentanyl–Involved Overdose Deaths with Detected Xylazine — United States, January 2019–June 2022.
Kariisa M, O’Donnell J, Kumar S, Mattson CL, Goldberger BA.
MMWR Morb Mortal Wkly Rep 2023;72:721–727. doi.org/10.15585/mmwr.mm7226a4
https://www.cdc.gov/mmwr/volumes/72/wr/mm7226a4.htm
Understanding intentionality of fentanyl use and drug overdose risk: Findings from a mixed methods study of people who inject drugs in New York City,
Courtney McKnight, Chenziheng Allen Weng, Marley Reynoso, Sarah Kimball, Lily M. Thompson, Don Des Jarlais,
International Journal of Drug Policy, Volume 118, 2023, 104063, ISSN 0955-3959,doi.org/10.1016/j.drugpo.2023.104063
https://www.sciencedirect.com/science/article/pii/S0955395923001111
Fentanyl - Informationen für Suchtfachpersonen – Faktenblatt,
Herausgeber: InfodroG, Schweizerische Koordeinations- und Fachstelle Sucht, Bern, 2023
https://www.infodrog.ch/files/content/factsheets/2023-08_infodrog_faktenblatt_fentanyl_de.pdf
The emerging fentanyl–xylazine syndemic in the USA: challenges and future directions
Zhu, David T et al.
The Lancet, Volume 0, Issue 0
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01686-0/fulltext
Focus on fentanyl in females: Sex and gender differences in the physiological and behavioral effects of fentanyl.
Little KM, Kosten TA.
Front Neuroendocrinol. 2023 Aug 18;71:101096. doi: 10.1016/j.yfrne.2023.101096. Epub ahead of print. PMID: 37597668.
Abstract
https://www.sciencedirect.com/science/article/abs/pii/S0091302223000444
Fentanyl Facts and Overdose Risk: An Addiction Policy Forum Course
Welcome to our course on Fentanyl Facts and Increased Overdose Risk. This course was developed by the Addiction Policy Forum and JCOIN to share facts about fentanyl in the U.S., increasing overdose risk, resources for communities, and myths and misconceptions. The course takes approximately 20 minutes to complete. (Addiction Policy Forum and JCOIN, USA, 2023)
https://www.jcoinctc.org/courses/fentanyl-facts-and-overdose-risk-an-apf-course/
Fentanyl and other New Psychoactive Synthetic Opioids. Challenges to Prevention and Treatment.
Albores-García D, Cruz SL.
Rev Invest Clin. 2023;75(3):93-104. doi: 10.24875/RIC.23000109. PMID: 37441771.
https://clinicalandtranslationalinvestigation.com/frame_esp.php?id=461
Development of a neural network model to predict the presence of fentanyl in community drug samples.
Development of a neural network model to predict the presence of fentanyl in community drug samples.
Ti L, Grant CJ, Tobias S, Hore DK, Laing R, Marshall BDL (2023)
PLoS ONE 18(7): e0288656. doi.org/10.1371/journal.pone.0288656
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288656
Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada
Kennedy, Mary Clare et al.
American Journal of Preventive Medicine, Volume 0, Issue 0
Abstract
https://www.ajpmonline.org/article/S0749-3797(23)00342-2/fulltext
Fentanyl and other New Psychoactive Synthetic Opioids. Challenges to Prevention and Treatment.
Albores-García D, Cruz SL.
Rev Invest Clin. 2023;75(3):93-104. doi: 10.24875/RIC.23000109. PMID: 37441771.
https://www.clinicalandtranslationalinvestigation.com/frame_esp.php?id=461
Understanding intentionality of fentanyl use and drug overdose risk: Findings from a mixed methods study of people who inject drugs in New York City.
McKnight C, Weng CA, Reynoso M, Kimball S, Thompson LM, Jarlais DD.
Int J Drug Policy. 2023 May 16:104063. doi: 10.1016/j.drugpo.2023.104063. Epub ahead of print. PMID: 37270373.
https://www.sciencedirect.com/science/article/pii/S0955395923001111
Testing for Fentanyl — Urgent Need for Practice-Relevant and Public Health Research
Nora D. Volkow, Robert M. Califf, Marta Sokolowska, Lawrence A. Tabak, and Wilson M. Compton
NEJM, June 10, 2023, DOI: 10.1056/NEJMp2302857
https://www.nejm.org/doi/full/10.1056/NEJMp2302857
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl.
Bird HE, Huhn AS, Dunn KE.
J Addict Med. 2023 May 17. doi: 10.1097/ADM.0000000000001185. Epub ahead of print. PMID: 37195789.
Abstract
https://journals.lww.com/journaladdictionmedicine/Abstract/9900/Fentanyl_Absorption,_Distribution,_Metabolism,_and.185.aspx
"Just another thing for me to stress off of:" Responses to Unintentional Fentanyl Use in a Community-based Study of People who Use Opioids.
Lorvick J, Hemberg J, George M, Piontak J, Comfort M.
Res Sq [Preprint]. 2023 Apr 27:rs.3.rs-2842551. doi: 10.21203/rs.3.rs-2842551/v1. PMID: 37162894; PMCID: PMC10168448.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168448/
Enumerating contributions of fentanyls and other factors to the unprecedented 2020 rise in opioid overdose deaths: model-based analysis.
Stringfellow EJ, Lim TY, DiGennaro C, Hasgul Z, Jalali MS.
PNAS Nexus. 2023 Mar 3;2(4):pgad064. doi: 10.1093/pnasnexus/pgad064. PMID: 37020497; PMCID: PMC10069612.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069612/
Clinical Provider Quick Tips - Addressing Substance Use in Primary Care Settings
Fentanyl Quick Tips
Fentanyl use trends, overdose risks and tools for reducing risk, and relevant medications for opioid use disorders (MOUD) to treat patients within emergency department and primary care settings. (UCLA – University of Califonia Los Angeles, USA, aufgerufen am 13.03.2023)
https://www.uclaisap.org/clinicalproviderquicktips/fentanyl-quick-tips.html
Synthetische Opioide in Deutschland - Bundesmodellprojekt RAFT (Präsentation)
Rapid Fentanyl Tests in Drogenkonsumräumen (12/22-11/23)
Projektleitung: Maria Kuban
Projektbegleitung: Dirk Schäffer
(Deutsche AIDS-Hilfe, Gefördert durch Bundesministerium für Gesundheit)
Synthetische Opioide in Deutschland - Bundesmodellprojekt RAFT (Präsentation)
Rapid Fentanyl Tests in Drogenkonsumräumen (12/22-11/23)
Projektleitung: Maria Kuban
Projektbegleitung: Dirk Schäffer
(Deutsche AIDS-Hilfe, Gefördert durch Bundesministerium für Gesundheit)
USA. DEA-Themenseite zu Fentanyl: “One Pill can kill”
Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops.
Nielsen S, Barratt M, Hiley S, Bartlett M, Latimer J, Jauncey M, Roux C, Morelato M, Clark N, Kowalski M, Gilbert M, Francia L, Shipton A, Gerostamoulos D, Glowacki L, Lam T.
Int J Drug Policy. 2023 May;115:104015. doi: 10.1016/j.drugpo.2023.104015. Epub 2023 Apr 10. PMID: 37043848.
Abstract
https://pubmed.ncbi.nlm.nih.gov/37043848/
Correlates of Heroin Use, Pharmaceutical Fentanyl Misuse, and Dual Heroin-Fentanyl Use: Evidence from the U.S.
Kelly BC, Vuolo M.
Drugs Habits Soc Policy. 2023 Mar;24(1):14-25. doi: 10.1108/dhs-04-2022-0019. Epub 2022 Sep 22. PMID: 37101522; PMCID: PMC10128616.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128616/
Fentanyl-driven acceleration of racial, gender and geographical disparities in drug overdose deaths in the United States.
D'Orsogna MR, Böttcher L, Chou T.
PLOS Glob Public Health. 2023 Mar 22;3(3):e0000769. doi: 10.1371/journal.pgph.0000769. PMID: 36962959; PMCID: PMC10032521.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032521/
Webinar. Treatment Considerations in the Age of Fentanyl
Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers, and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment.
Presenters will discuss practical clinical practice-based guidance on treating opioid use disorder in the age of fentanyl, the use of medications for opioid use disorder (MOUD) in the treatment of individuals using fentanyl, and other considerations and challenges. The free webinar from the Justice Community Opioid Innovation Network (JCOIN) at the National Institute on Drug Abuse (NIDA), in partnership with the American Academy of Addiction Psychiatry (AAAP), the Providers Clinical Support System (PCSS) and the Addiction Policy Forum.
https://us06web.zoom.us/webinar/register/WN_g8r16sesQhSk0AOxmawmLA
Fentanyl Facts and Overdose Risk: A DEA Educational Foundation Course
Welcome to our course on Fentanyl Facts and Increased Overdose Risk. This course was developed by the Addiction Policy Forum in partnership with the Drug Enforcement Administration (DEA) Educational Foundation and JCOIN to share facts about fentanyl in the U.S., increasing overdose risk, and resources for communities. The course takes approximately 20 minutes to complete. (JCOIN Coordination and Translation Center, Februar 2023)
https://www.jcoinctc.org/courses/fentanyl-facts-and-overdose-risk-a-dea-educational-foundation-course/
USA. Fentanyl Facts and Overdose Risk: An Addiction Policy Forum Course
This course (20 Minuten, Anm. Forum Substitutionspraxis) was developed by the Addiction Policy Forum and JCOIN to share facts about fentanyl in the U.S., increasing overdose risk, resources for communities, and myths and misconceptions. The course takes approximately 20 minutes to complete. (Addiction Policy Forum and JCOIN, USA, Februar 2023)
https://www.jcoinctc.org/courses/fentanyl-facts-and-overdose-risk-an-apf-course/
Illicit Non-Pharmaceutical Fentanyl and Its Analogs: A Short Review of Literature.
Velagapudi V, Sethi R.
Kans J Med. 2023 Jan 18;16:25-27. doi: 10.17161/kjm.vol16.18555. PMID: 36703950; PMCID: PMC9872502.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872502/
Just Say KNOW: Fentanyl, Fakery & the New Drug Talk.
Ed, Ternan M.
Mo Med. 2022 Nov-Dec;119(6):487-488. PMID: 36588636; PMCID: PMC9762230.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762230/
Wooden chest syndrome: A curious case of fentanyl induced rigidity in adults.
Baruah U, Gaur H, Saigal D, Pandey D.
Indian J Anaesth. 2022 Dec;66(12):881-882. doi: 10.4103/ija.ija_171_22. Epub 2022 Dec 20. PMID: 36654889; PMCID: PMC9842087.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842087/
Atypical Fentanyl Transdermal Patch Consumption and Fatalities: Case Report and Literature Review.
Manetti F, David MC, Gariglio S, Consalvo F, Padovano M, Scopetti M, Grande A, Santurro A.
Toxics. 2022 Dec 31;11(1):46. doi: 10.3390/toxics11010046. PMID: 36668772; PMCID: PMC9863810.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863810/
Seite 1 von 9